These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 20815703)

  • 1. Serological correlate of protection against norovirus-induced gastroenteritis.
    Reeck A; Kavanagh O; Estes MK; Opekun AR; Gilger MA; Graham DY; Atmar RL
    J Infect Dis; 2010 Oct; 202(8):1212-8. PubMed ID: 20815703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal and Cellular Immune Responses to Norwalk Virus.
    Ramani S; Neill FH; Opekun AR; Gilger MA; Graham DY; Estes MK; Atmar RL
    J Infect Dis; 2015 Aug; 212(3):397-405. PubMed ID: 25635121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children.
    Malm M; Uusi-Kerttula H; Vesikari T; Blazevic V
    J Infect Dis; 2014 Dec; 210(11):1755-62. PubMed ID: 24970849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus.
    Czakó R; Atmar RL; Opekun AR; Gilger MA; Graham DY; Estes MK
    Clin Vaccine Immunol; 2012 Feb; 19(2):284-7. PubMed ID: 22190401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological Correlates of Protection against a GII.4 Norovirus.
    Atmar RL; Bernstein DI; Lyon GM; Treanor JJ; Al-Ibrahim MS; Graham DY; Vinjé J; Jiang X; Gregoricus N; Frenck RW; Moe CL; Chen WH; Ferreira J; Barrett J; Opekun AR; Estes MK; Borkowski A; Baehner F; Goodwin R; Edmonds A; Mendelman PM
    Clin Vaccine Immunol; 2015 Aug; 22(8):923-9. PubMed ID: 26041041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-Host Interactions Between Nonsecretors and Human Norovirus.
    Lindesmith LC; Brewer-Jensen PD; Mallory ML; Jensen K; Yount BL; Costantini V; Collins MH; Edwards CE; Sheahan TP; Vinjé J; Baric RS
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):245-267. PubMed ID: 32289501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.
    Sapparapu G; Czakó R; Alvarado G; Shanker S; Prasad BV; Atmar RL; Estes MK; Crowe JE
    PLoS Pathog; 2016 Jun; 12(6):e1005719. PubMed ID: 27355511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection.
    Kirby AE; Shi J; Montes J; Lichtenstein M; Moe CL
    J Med Virol; 2014 Dec; 86(12):2055-64. PubMed ID: 24531909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterotypic humoral and cellular immune responses following Norwalk virus infection.
    Lindesmith LC; Donaldson E; Leon J; Moe CL; Frelinger JA; Johnston RE; Weber DJ; Baric RS
    J Virol; 2010 Feb; 84(4):1800-15. PubMed ID: 20007270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis.
    Chen Z; Sosnovtsev SV; Bok K; Parra GI; Makiya M; Agulto L; Green KY; Purcell RH
    J Virol; 2013 Sep; 87(17):9547-57. PubMed ID: 23785216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less severe clinical symptoms of Norwalk virus 8fIIb inoculum compared to its precursor 8fIIa from human challenge studies.
    Liu P; Rahman M; Leon J; Moe C
    J Med Virol; 2021 Jun; 93(6):3557-3563. PubMed ID: 33017074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of histo-blood group antigens and susceptibility to norovirus infections.
    Rockx BH; Vennema H; Hoebe CJ; Duizer E; Koopmans MP
    J Infect Dis; 2005 Mar; 191(5):749-54. PubMed ID: 15688291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and humoral immunity following Snow Mountain virus challenge.
    Lindesmith L; Moe C; Lependu J; Frelinger JA; Treanor J; Baric RS
    J Virol; 2005 Mar; 79(5):2900-9. PubMed ID: 15709009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of Norwalk virus and Mexico virus infections at Ga-Rankuwa Hospital, Ga-Rankuwa, South Africa.
    Smit TK; Steele AD; Peenze I; Jiang X; Estes MK
    J Clin Microbiol; 1997 Sep; 35(9):2381-5. PubMed ID: 9276420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995.
    Noel JS; Ando T; Leite JP; Green KY; Dingle KE; Estes MK; Seto Y; Monroe SS; Glass RI
    J Med Virol; 1997 Dec; 53(4):372-83. PubMed ID: 9407386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of homologous and cross-reactive GII.4-specific blocking antibodies in children after GII.4 New Orleans norovirus infection.
    Blazevic V; Malm M; Vesikari T
    J Med Virol; 2015 Oct; 87(10):1656-61. PubMed ID: 25946711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
    Mateo R; Lindesmith LC; Garg SJ; Gottlieb K; Lin K; Said S; Leon JS; Sims AC; Weber DJ; Baric RS; Tucker SN; Taylor DN
    J Infect Dis; 2020 Mar; 221(6):919-926. PubMed ID: 31628848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers.
    Griffin SM; Converse RR; Leon JS; Wade TJ; Jiang X; Moe CL; Egorov AI
    J Immunol Methods; 2015 Sep; 424():53-63. PubMed ID: 25985985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the 50% human infectious dose for Norwalk virus.
    Atmar RL; Opekun AR; Gilger MA; Estes MK; Crawford SE; Neill FH; Ramani S; Hill H; Ferreira J; Graham DY
    J Infect Dis; 2014 Apr; 209(7):1016-22. PubMed ID: 24253285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.